Woman smiling as she walks outside

The Janssen Portfolio of Long-Acting Injections

Featuring INVEGA SUSTENNA® and INVEGA TRINZA®. Same active ingredient, different long-acting treatment options for adult patients with schizophrenia.

Woman resting her face on her hands, smiling
Red geometric icon

What long-acting treatments can offer

You didn’t choose to live with schizophrenia, but you have a choice in how you manage it. It’s important to talk with your healthcare professional and learn about all the treatment options available to you, like a long-term approach to treatment with either INVEGA SUSTENNA® (paliperidone palmitate) and INVEGA TRINZA® (paliperidone palmitate) from the Janssen portfolio of long-acting injections (LAIs).

Treatment with LAIs can help you feel confident that the medication you need is in your system for a month* or 3 months** with a single dose. LAIs can also help control schizophrenia symptoms in adults and help delay another episode.

In a pivotal long-term study, 90% of adult patients taking INVEGA SUSTENNA® did not experience a significant return of schizophrenia symptoms vs 66% of those not treated. In a separate pivotal long-term study, 93% of adult patients taking INVEGA TRINZA® did not experience a significant return of schizophrenia symptoms vs 77% of those not treated.

The Janssen portfolio of LAIs has 2 treatment options with the same active ingredient, both designed to be gradually released to help control schizophrenia symptoms and delay time to another relapse in adults. INVEGA SUSTENNA® is given every month after 2 starting doses, and INVEGA TRINZA® is given once every 3 months to patients after they have been adequately treated with INVEGA SUSTENNA® for at least 4 months.

*After receiving 2 starting doses when treating with INVEGA SUSTENNA®.

**When treating with INVEGA TRINZA® after being adequately treated with INVEGA SUSTENNA® for approximately 4 months.

* Elizabeth is a volunteer with the SHARE Network, a volunteer program dedicated to helping adults living with schizophrenia share their personal health stories.

Real advice from 
real patients*

Learn about LAIs

Potential side 
effects

As with any medicine, INVEGA SUSTENNA® or INVEGA TRINZA® may cause side effects in some people, so the risks are important to consider as you and your healthcare professional make decisions about your treatment.

The most common side effects for INVEGA SUSTENNA® include: injection site reactions, sleepiness or drowsiness, dizziness, feeling of inner restlessness or needing to be constantly moving, and abnormal muscle movements, including tremor (shaking), shuffling, uncontrolled involuntary movements, and abnormal movements of your eyes.

The most common side effects of INVEGA TRINZA® include: injection site reactions, weight gain, headache, upper respiratory tract infections, feeling restlessness or difficulty sitting still, slow movements, tremors, stiffness and shuffling walk.

Tell your Treatment Team if you have any side effect that bothers you or does not go away.